5 Best Healthcare Technology Stocks To Watch Right Now

Related TLT How Bond ETF Flows Affect ETF Sponsors Boring Bonds Boost ETF Asset Growth Related IWM Fast Money Picks For March 10 Fast Money Picks For March 8 Financial Risks: ECB Overstimulation (Seeking Alpha)

On Friday, CNBC’s "Fast Money" traders shared three moves to make after Draghi said the European Central Bank would not be boosting rates any further.

Guy Adami recommended the iShares Barclays 20+ Yr Treas.Bond (ETF) (NASDAQ: TLT). Considering what is going on in the world, U.S.’ 10-year bond at 1.8 percent looks “pretty attractive against a landscape of negative interest rates globally,” the analyst commented.

5 Best Healthcare Technology Stocks To Watch Right Now: LyondellBasell Industries NV(LYB)

LyondellBasell Industries N.V. manufacturers and sells chemicals and polymers, refines crude oil, produces gasoline blending components, and develops and licenses technologies for production of polymers. The company?s Olefins and Polyolefins segment offers olefins, including ethylene, propylene, and butadiene; aromatics, such as benzene and toluene; polyolefins, which comprise polypropylene (PP), high-density polyethylene, low-density polyethylene, and linear low-density polyethylene; specialty polyolefins, including catalloy process resins, PP compounds, and polybutene-1 resins; and ethylene derivatives, which comprise ethanol. Its Intermediates and Derivatives segment provides propylene oxide (PO); PO co-products, including styrene monomers and TBA derivative isobutylene; PO derivatives, such as propylene glycol, propylene glycol ethers, and butanediol; acetyls, such as methanol, acetic acid, and vinyl acetate monomers; ethylene derivatives, which comprise ethylene oxide , ethylene glycol, and ethylene glycol ethers; and flavor and fragrance chemicals. The company?s Refining and Oxyfuels segment offers gasoline and components, ultra low sulfur diesel, jet fuel, and lube oils; diesel, feedstock, fuel oil, gasoline, and bitumen; and gasoline blending components, including methyl tertiary butyl ether, ethyl tertiary butyl ether, and alkylate. Its Technology segment develops and licenses polyolefin and other process technologies. This segment also develops, manufactures, and sells polyolefin catalysts, as well as provides technology services, which comprise safety reviews, training and start-up assistance, engineering services for process and product improvements, and manufacturing troubleshooting. LyondellBasell Industries N.V. has operations in the Americas, Europe, Asia, and internationally. The company was founded in 2005 and is based in Rotterdam, Netherlands. LyondellBasell Industries N.V. is a subsidiary of Prochemie GmbH.

Advisors’ Opinion:

  • [By Chad Tracy]

    TransCanada is not the only company that stands to profit from the possible Keystone XL approval. Refiners such as Valero and LyondellBasell Industries (NYSE: LYB), as well as construction companies Deere & Co. (NYSE: DE) and Quanta Services (NYSE: PWR) all stand to gain if Keystone XL gets the green light.

  • [By Chad Tracy]

    In a classic contrarian move, he purchased more shares of troubled plastics-maker LyondellBasell Industries (NYSE: LYB), even as the company was sliding toward bankruptcy.

5 Best Healthcare Technology Stocks To Watch Right Now: CSX Corporation(CSX)

CSX Corporation, together with its subsidiaries, incorporated on November 15, 1978, is a transportation company. The Company provides rail-based transportation services, including rail service and the transport of intermodal containers and trailers. The Company serves approximately three lines of business, such as merchandise business, coal business and intermodal business. The Company’s operating subsidiary, CSX Transportation, Inc. (CSXT), provides a link to the transportation supply chain through its approximately 21,000-route mile rail network, which serves population centers in approximately 20 states east of the Mississippi River, the District of Columbia and the Canadian provinces of Ontario and Quebec. It has access to over 70 ocean, river and lake port terminals along the Atlantic and Gulf Coasts, the Mississippi River, the Great Lakes and the St. Lawrence Seaway. The Company’s intermodal business links customers to railroads through trucks and terminals. CSXT als o serves production and distribution facilities through track connections to approximately 240 short-line and regional railroads.

The Company’s merchandise business consists of shipments in the diverse markets, such as agricultural products, phosphates and fertilizers, food and consumer, chemicals, automotive, metals, forest products, minerals, and waste and equipment. The Company’s coal business transports domestic coal, coke and iron ore to electricity-generating power plants, steel manufacturers and industrial plants, as well as exports coal to deep-water port facilities. The Company’s intermodal business combines the rail transportation with the short-haul flexibility of trucks and offers long-haul trucking. The Company’s intermodal business serves all markets, which are located in east of the Mississippi River, and transports manufactured consumer goods in containers. The Company provides customers with truck-like service for longer shipments.

In addition to CSXT, the Company’s subsidiaries include CSX ! Intermodal Terminals, Inc. (CSX Intermodal Terminals), Total Distribution Services, Inc. (TDSI), Transflo Terminal Services, Inc. (Transflo), CSX Technology, Inc. (CSX Technology) and other subsidiaries. CSX Intermodal Terminals owns and operates a system of intermodal terminals, predominantly in the eastern United States, and also performs drayage services (the pickup and delivery of intermodal shipments) for certain customers and trucking dispatch operations. TDSI serves the automotive industry with distribution centers and storage locations. Transflo transfers products from rail to trucks. The Transflo markets are chemicals and agriculture, which include shipments of plastics and ethanol. CSX Technology and other subsidiaries provide support services for the Company. CSX’s other holdings include CSX Real Property, Inc., a subsidiary responsible for the Company’s operating and non-operating real estate sales, leasing, acquisition, and management and development activities.

The Company competes with Norfolk Southern Railway.

Advisors’ Opinion:

  • [By Monica Gerson]

    CSX Corporation (NASDAQ: CSX) is expected to post its quarterly earnings at $0.37 per share on revenue of $2.68 billion.

    ADTRAN, Inc. (NASDAQ: ADTN) is projected to post its quarterly earnings at $0.08 per share on revenue of $141.07 million.

  • [By Monica Gerson]

    CSX Corporation (NASDAQ: CSX) reported in-line earnings for its first quarter, but the company missed analysts’ sales estimates. CSX shares gained 0.44 percent to $25.10 in after-hours trading.

Hot Companies For 2017: Mead Johnson Nutrition Company(MJN)

Mead Johnson Nutrition Company (Mead Johnson), incorporated on December 17, 2008, is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

The Company’s product portfolio, which addresses a range of pediatric nutritional needs, consists of two principal product categories: infant formula and children’s nutrition. The product categories are categorized into approximately five product types: routine infant, solutions, specialty, children’s nutrition and other. Its routine infant formula is intended for healthy consumers while its solutions and specialty products are offered for infants with special nutritional needs. The Company’s children’s’ nutrition products are designed to meet the nutritional needs of children at different stages of development. Its other products include vitamins and supplements.

Routine Infant Formula

The Company designs routine infant formula as a breast milk substitute for full-term infants without special nutritional needs both for the use as the infant’s source of nutrition and as a supplement to breastfeeding. Each product is referred to as a formula, as it is formulated for the specific nutritional needs of an i! nfant at a given age. Its routine infant formulas has over four components: protein from cow’s milk that is processed to have a profile similar to human milk; a blend of vegetable fats, including docosahexaenoic acid (DHA) and arachidonic acid (ARA), to replace bovine milk fat in order to resemble the composition of human milk; a carbohydrate, generally lactose from cow’s milk, and a vitamin and mineral micronutrient pre-mix that is blended into the product to meet the specific needs of the infant at a given age. The Company’s routine infant formula products include Enfamil Premium, Enfapro Premium, Enfamil A+ and Enfalac A+.

Solutions Products

The Company designs several solutions formulas to address common feeding tolerance problems, including spit-up, fussiness, gas and lactose intolerance. Its solutions products include Enfamil Gentlease (for fussiness and gas), Enfamil A.R. (to reduce spit-up), Enfamil ProSobee (a soy-based formula) and Enfamil LactoFree (for lactose intolerance).

Specialty Products

The Company designs specialty formulas to address certain conditions or special medical needs, including Nutramigen (for cow’s milk protein allergies) and Puramino (an amino acid formula for severe cow’s milk protein allergies or multiple other food allergies). The Company designs products, such as Enfamil Premature to meet the needs of premature and low birth weight infants under the supervision of a doctor, most often in the hospital, and EnfaCare, a hypercaloric formula for premature babies at home. It also produces medical foods, or foods for special medical purposes, for nutritional management of individuals with rare, inborn errors of metabolism, such as maple syrup urine disease (Mead Johnson BCAD) and phenylketonuria (Mead Johnson Phenyl-Free). Certain of these products are intended for infants and young children while others are suitable for children and adults.

Children’ s Nutrition Products

The Company designs its ch! ildren’s ! products to meet the nutritional needs of children at different stages of development (such as toddlers and older children). Its children’s nutrition products include Enfagrow, Sustagen and Lactum. These products are not breast milk substitutes and are not designed as a sole source of nutrition but instead are designed to be a part of a child’s diet. The Company also offers milk modifiers (ChocoMilk and Cal-C-Tose).

Other Products

The Company also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers, including Expecta and EnfaMama. Its pediatric vitamin products sold in a few geographies, such as Enfamil Poly-Vi-Sol, provide a range of benefits for infants, including multivitamins and iron supplements.

The Company competes with Abbott Laboratories, Danone and Nestle.

Advisors’ Opinion:

  • [By Michael Flannelly]

    On Tuesday, JP Morgan analysts upgraded children’s nutrition company Mead Johnson Nutrition (MJN), as they believe the company’s top line growth should be valued more highly than the possible cost headwinds and further Chinese regulations.

    The analysts upgraded MJN from “Neutral” to “Overweight” and see shares reaching $88. This price target suggests a 16% upside to the stock’s Monday closing price of $76.11.

    Mead Johnson Nutrition shares were up 85 cents, or 1.12%, during morning trading on Tuesday. The stock is up 16.71% year-to-date.

5 Best Healthcare Technology Stocks To Watch Right Now: 1-800 FLOWERS.COM Inc.(FLWS)

1-800-Flowers.com, Inc. together with its subsidiaries, operates as a florist and gift retailer in the United States. The company offers a range of products, including fresh-cut flowers, floral arrangements and plants, gifts, popcorn, gourmet foods and gift baskets, cookies, chocolates, candy, and wine through its telephonic and online sales channels, company-owned and operated retail floral stores, and franchised stores. It provides gourmet gifts, such as popcorn and specialty treats through thepopcornfactory.com; cookies and baked gifts through cheryls.com; chocolates and confections through fanniemay.com and harrylondon.com; gift baskets and towers through 1800baskets.com; Celebrations brand party ideas and planning tips through celebrations.com; and customizable invitations, announcements, and greeting cards through finestationery.com. As of July 3, 2011, the company operated 2 floral retail stores, 1 fulfillment center, and approximately 100 franchised stores located within the United States. It has strategic online relationships with Facebook, Google, AOL, Yahoo!, and Microsoft. The company was founded in 1976 and is headquartered in Carle Place, New York.

Advisors’ Opinion:

  • [By Wayne Duggan]

    U.S. retailers performed poorly during the Christmas holiday season, but companies in the Valentine’s Day business are hoping that Americans will spend generously in the name of love this year. These names include flower delivery company 1-800-Flowers.Com Inc (NASDAQ: FLWS), L Brands Inc (NYSE: LB) (owner of both Victoria’s Secret and Bath & Body Works), Church & Dwight Co., Inc. (NYSE: CHD) (owner of Trojan brand condoms), candy giant Hershey Co (NYSE: HSY) and luxury jeweler Tiffany & Co. (NYSE: TIF).

5 Best Healthcare Technology Stocks To Watch Right Now: LCA-Vision Inc.(LCAV)

LCA-Vision Inc. provides fixed-site laser vision correction services through its LasikPlus vision centers. Its vision centers offer laser vision correction services for correcting nearsightedness, farsightedness, and astigmatism. As of December 31, 2011, the company operated 53 LasikPlus fixed-site laser vision correction centers located in metropolitan markets in the United States. LCA-Vision Inc. was founded in 1985 and is headquartered in Cincinnati, Ohio.

Advisors’ Opinion:

  • [By Lisa Levin]

    Medical Practitioners: This industry jumped 2.82% by 10:15 am. The top performer in this industry was LCA-Vision (NASDAQ: LCAV), which rose 2.9%. LCA-Vision’s trailing-twelve-month revenue is $91.12 million.